TY - JOUR
T1 - Disparities in the management and outcome of cervical cancer in the United States according to health insurance status
AU - Churilla, Thomas
AU - Egleston, Brian
AU - Dong, Yanqun
AU - Shaikh, Talha
AU - Murphy, Colin
AU - Mantia-Smaldone, Gina
AU - Chu, Christina
AU - Rubin, Stephen
AU - Anderson, Penny
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/6
Y1 - 2016/6
N2 - Introduction Our study sought to characterize the presentation, local management and outcomes of invasive cervical cancer with regard to patient insurance status. Methods We queried the NCI-SEER database for invasive cervical cancer cases in patients aged 18–64 from 2007 to 2011. We analyzed clinical and socioeconomic data with regard insurance status (insured, Medicaid, or uninsured). We tested for associations between patient insurance status and treatment with definitive surgery for FIGO IA2-IB1 patients, and treatment with suboptimal radiation therapy (RT) for FIGO IB2-IVA patients (other than combination external beam and brachytherapy). We evaluated overall and cause specific survival according to insurance status. Results 11,714 cases were analyzed: 60% insured, 31% Medicaid, and 9% uninsured. FIGO III/IV stage at presentation was more frequent with Medicaid (40%) and uninsured (42%) compared to insured patients (28%) (p < 0.001). For FIGO IA2-IB1 patients, receipt of definitive surgery was inversely associated with uninsured status (OR [95%CI] = 0.65 [0.47–0.90], p < 0.001) in univariable analysis; however the relationship lost significance after multivariable adjustment. For FIGO IB2-IVA patients, the use of suboptimal RT was associated with uninsured status (OR [95%CI] = 1.33 [1.07–1.65], p = 0.011) in adjusted analyses. Among all patients, overall mortality was increased with Medicaid (HR [95%CI] = 1.16 [1.05–1.28], p = 0.003) and uninsured status (HR [95%CI] = 1.17 [1.01–1.34], p = 0.031) in multivariable analysis. Cancer specific mortality survival trended towards significance in multivariable analyses for both Medicaid (HR [95%CI] = 1.11 [1.00–1.24] and uninsured status (HR [95%CI] = 1.14 [0.98–1.33]). Conclusions Disparities in cervical cancer treatment with regard to insurance status are apparent in a recent cohort of American patients. Later stage at presentation and differences in management partially account for the inferior prognostic outcomes associated with Medicaid and uninsured status.
AB - Introduction Our study sought to characterize the presentation, local management and outcomes of invasive cervical cancer with regard to patient insurance status. Methods We queried the NCI-SEER database for invasive cervical cancer cases in patients aged 18–64 from 2007 to 2011. We analyzed clinical and socioeconomic data with regard insurance status (insured, Medicaid, or uninsured). We tested for associations between patient insurance status and treatment with definitive surgery for FIGO IA2-IB1 patients, and treatment with suboptimal radiation therapy (RT) for FIGO IB2-IVA patients (other than combination external beam and brachytherapy). We evaluated overall and cause specific survival according to insurance status. Results 11,714 cases were analyzed: 60% insured, 31% Medicaid, and 9% uninsured. FIGO III/IV stage at presentation was more frequent with Medicaid (40%) and uninsured (42%) compared to insured patients (28%) (p < 0.001). For FIGO IA2-IB1 patients, receipt of definitive surgery was inversely associated with uninsured status (OR [95%CI] = 0.65 [0.47–0.90], p < 0.001) in univariable analysis; however the relationship lost significance after multivariable adjustment. For FIGO IB2-IVA patients, the use of suboptimal RT was associated with uninsured status (OR [95%CI] = 1.33 [1.07–1.65], p = 0.011) in adjusted analyses. Among all patients, overall mortality was increased with Medicaid (HR [95%CI] = 1.16 [1.05–1.28], p = 0.003) and uninsured status (HR [95%CI] = 1.17 [1.01–1.34], p = 0.031) in multivariable analysis. Cancer specific mortality survival trended towards significance in multivariable analyses for both Medicaid (HR [95%CI] = 1.11 [1.00–1.24] and uninsured status (HR [95%CI] = 1.14 [0.98–1.33]). Conclusions Disparities in cervical cancer treatment with regard to insurance status are apparent in a recent cohort of American patients. Later stage at presentation and differences in management partially account for the inferior prognostic outcomes associated with Medicaid and uninsured status.
UR - http://www.scopus.com/inward/record.url?scp=84961842661&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000377626500022&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1016/j.ygyno.2016.03.025
DO - 10.1016/j.ygyno.2016.03.025
M3 - Article
C2 - 27012428
SN - 0090-8258
VL - 141
SP - 516
EP - 523
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -